REGN
Regeneron Pharmaceuticals, Inc. · Healthcare · Biotechnology
TECHSellZACKSHold
R500#286 today
$735.20
+0.05% today · -6.71% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- REGN +0.05% on the last session vs SPY +0.74%: −0.7 pts of stock-specific move.
- Aftermath, big drop (Sep 28): After its 60 big drops in the past 5 years, REGN typically gained 1.4% over the next month (median) and was higher 58% of the time; half the outcomes fell between -4.6% and +5.9%. An ordinary month: +1.1%. Among S&P 500 stocks after big drops, that ranks #275 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
REGN against the S&P 500 components
| Window | Rank of 500 | Position | Gain | SPY gain |
|---|---|---|---|---|
| 1 day | #286 | +0.05% | +0.74% | |
| 1 week | #486 | -6.71% | -0.22% | |
| 1 month | #445 | -13.71% | +0.84% | |
| 3 months | #66 | +12.50% | +3.59% | |
| 6 months | #333 | -3.24% | +17.95% | |
| 1 year | #149 | +23.16% | +16.25% | |
| Overall | #327 | sum of the six window ranks, ranked again | ||
R500 ranks the stock's gain over each window against the S&P 500 components over the same window (#1 = best). Near-real-time during market hours.
Fundamentals Biotechnology
| Metric | Value | Rank in S&P 500 | Rank in industry |
|---|---|---|---|
| Targeted Gain Median | 0.17 | #307 | #1 |
| fPE/tPE | 0.66 | #158 | #2 |
| PE/G | 1.25 | #185 | #1 |
| EV/Revenue | 4.38 | #212 | #4 |
| Gross Margin | 0.44 | #252 | #4 |
| Profit Margin | 0.28 | #78 | #2 |
| Revenue Growth | 0.17 | #142 | #2 |